Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Yiling Pharmaceutical doubled its performance through innovation in 2020 2021-04-12 17:07
Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting 2021-04-10 21:33
HealthyRecipes101.com Offers Free Access to 300 Nutritionist-approved Recipes 2021-04-09 22:44
Bionomics Successfully Completes A$22.9 million Equity Raise 2021-04-09 18:00
Control Bionics (ASX:CBL) Partners with Numotion as Northeastern U.S. Reseller of Assistive Technology Solutions 2021-04-09 04:16
ImmVira Announces Preclinical and Clinical Data to Be Presented at the 2021 ASCO and AACR Annual Meeting 2021-04-08 20:47
Hyundai Bioscience leads in the repurposing of Niclosamide 2021-04-08 17:17
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-176 in EGFR-Mutant NSCLC with C797S 2021-04-07 06:00
Brattea, a Leading Renal Denervation Company in China, Completes over $US20 Million Series B+ Financing, led by Kuanping Capital 2021-04-06 20:00
MitoImmune Received FDA Clearance of IND Application for MIT-001, a Novel Anti-Inflammatory/Anti-Necrotic Therapy for Oral Mucositis in CCRT patients with Head and Neck Cancer 2021-04-06 20:00
US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002 2021-04-02 13:40
Neurophth Announces IND Approval by the NMPA for Leber Hereditary Optic Neuropathy Gene Therapy 2021-04-01 20:39
Molecular Data Inc. intends to further upgrade its digital tools using Blockchain 2021-04-01 19:00
Jolly Good Newly Establishes CBT VR Specialist Department with Clinical Psychiatrists 2021-04-01 16:00
Yingli Pharma announce promising topline results of a Phase II registration study for treatment of relapsed/refractory follicular lymphoma with the once daily oral PI3Kδ inhibitor, linperlisib 2021-04-01 14:09
Gracell Biotechnologies Signs Agreement with Lonza to Manufacture Gracell's FasTCAR Product Candidates in the U.S. 2021-03-31 20:45
VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper 2021-03-31 20:30
Gracell Biotechnologies Announces Enrollment of First Patient in Registrational Phase 1/2 Clinical Study for GC007g, an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL 2021-03-31 20:00
AffaMed Therapeutics and SIFI Announce Joint Venture to Serve Greater China Market 2021-03-31 19:30
3SBio announces 2020 annual results, tapping integrated platform advantages for steady growth 2021-03-31 09:11